Literature DB >> 16039971

AMP-activated protein kinase: a key stress signaling pathway in the heart.

Lawrence H Young1, Ji Li, Suzanne J Baron, Raymond R Russell.   

Abstract

AMP-activated protein kinase (AMPK) is activated during exercise and ischemia and is emerging as an important regulatory mechanism in the heart. AMPK promotes adenosine triphosphate-generating pathways, including glucose transport, glycolysis, and fatty acid oxidation, while inhibiting energy-consuming anabolic pathways. After ischemia-reperfusion, AMPK-deficient hearts from transgenic mice have severe left ventricular contractile dysfunction with increased apoptosis and necrosis. Mutations in the AMPKgamma(2) subunit lead to cardiac glycogen overload, Wolff-Parkinson-White syndrome, arrhythmias, and heart failure. This review focuses on the molecular mechanisms of activation and cardiovascular actions of AMPK in the heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039971     DOI: 10.1016/j.tcm.2005.04.005

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  62 in total

1.  Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in Type 1 diabetic murine cardiomyocytes.

Authors:  Chao Tong; Alex Morrison; Xiaoyan Yan; Peng Zhao; Eddie D Yeung; Jingying Wang; Jianxin Xie; Ji Li
Journal:  J Diabetes       Date:  2010-12       Impact factor: 4.006

2.  AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.

Authors:  Benjamin R Nixon; Ariyoporn Thawornkaiwong; Janel Jin; Elizabeth A Brundage; Sean C Little; Jonathan P Davis; R John Solaro; Brandon J Biesiadecki
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

Review 3.  Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.

Authors:  Stephen L Archer; E Kenneth Weir; Martin R Wilkins
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

4.  A novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3.

Authors:  Jingying Wang; Heng Ma; Xiaoyu Zhang; Leilei He; Jianming Wu; Xiaoping Gao; Jun Ren; Ji Li
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-03-25

Review 5.  Molecular imaging targets of cardiac remodeling.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

6.  AMP-activated protein kinase promotes human prostate cancer cell growth and survival.

Authors:  Hyeon Ung Park; Simeng Suy; Malika Danner; Vernon Dailey; Ying Zhang; Henghong Li; Daniel R Hyduke; Brian T Collins; Gregory Gagnon; Bhaskar Kallakury; Deepak Kumar; Milton L Brown; Albert Fornace; Anatoly Dritschilo; Sean P Collins
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

7.  Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.

Authors:  Ji Li; Dake Qi; Haiying Cheng; Xiaoyue Hu; Edward J Miller; Xiaohong Wu; Kerry S Russell; Nicole Mikush; Jiasheng Zhang; Lei Xiao; Robert S Sherwin; Lawrence H Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 8.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

9.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

10.  Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells.

Authors:  Jin-Taek Hwang; Dae Young Kwon; Ock Jin Park; Myung Sunny Kim
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.